Cecors Inc Stock Performance
CEOS Stock | USD 0.01 0.0004 5.13% |
The firm owns a Beta (Systematic Risk) of 4.0, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CeCors will likely underperform. At this point, CeCors Inc has a negative expected return of -0.43%. Please make sure to confirm CeCors' total risk alpha, as well as the relationship between the skewness and day median price , to decide if CeCors Inc performance from the past will be repeated at future time.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days CeCors Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Total Cashflows From Investing Activities | -69.5 K |
CeCors |
CeCors Relative Risk vs. Return Landscape
If you would invest 2.70 in CeCors Inc on December 19, 2024 and sell it today you would lose (1.88) from holding CeCors Inc or give up 69.63% of portfolio value over 90 days. CeCors Inc is currently does not generate positive expected returns and assumes 19.4485% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CeCors, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
CeCors Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CeCors' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CeCors Inc, and traders can use it to determine the average amount a CeCors' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0222
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CEOS |
Estimated Market Risk
19.45 actual daily | 96 96% of assets are less volatile |
Expected Return
-0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CeCors is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CeCors by adding CeCors to a well-diversified portfolio.
CeCors Fundamentals Growth
CeCors Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CeCors, and CeCors fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CeCors Pink Sheet performance.
Return On Equity | -7.26 | |||
Return On Asset | -1.8 | |||
Current Valuation | 87.7 K | |||
Price To Earning | (0.05) X | |||
EBITDA | (3.72 M) | |||
Cash And Equivalents | 57.42 K | |||
Total Debt | 956.88 K | |||
Book Value Per Share | (0.02) X | |||
Cash Flow From Operations | (6.88 M) | |||
Earnings Per Share | (0.41) X | |||
Total Asset | 2.26 M | |||
Retained Earnings | (33.91 M) | |||
Current Asset | 114 K | |||
Current Liabilities | 343 K | |||
About CeCors Performance
Assessing CeCors' fundamental ratios provides investors with valuable insights into CeCors' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the CeCors is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada. CECORS INC operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 6 people.Things to note about CeCors Inc performance evaluation
Checking the ongoing alerts about CeCors for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CeCors Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.CeCors Inc generated a negative expected return over the last 90 days | |
CeCors Inc has high historical volatility and very poor performance | |
CeCors Inc has some characteristics of a very speculative penny stock | |
CeCors Inc has a very high chance of going through financial distress in the upcoming years | |
CeCors Inc currently holds 956.88 K in liabilities. CeCors Inc has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist CeCors until it has trouble settling it off, either with new capital or with free cash flow. So, CeCors' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CeCors Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CeCors to invest in growth at high rates of return. When we think about CeCors' use of debt, we should always consider it together with cash and equity. | |
Net Loss for the year was (9.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
CeCors Inc currently holds about 57.42 K in cash with (6.88 M) of positive cash flow from operations. |
- Analyzing CeCors' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CeCors' stock is overvalued or undervalued compared to its peers.
- Examining CeCors' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CeCors' management team can have a significant impact on its success or failure. Reviewing the track record and experience of CeCors' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CeCors' pink sheet. These opinions can provide insight into CeCors' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CeCors Pink Sheet Analysis
When running CeCors' price analysis, check to measure CeCors' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CeCors is operating at the current time. Most of CeCors' value examination focuses on studying past and present price action to predict the probability of CeCors' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CeCors' price. Additionally, you may evaluate how the addition of CeCors to your portfolios can decrease your overall portfolio volatility.